Flagship explainer

What drives CORMEDIX INC.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity67%Tax burden109%net income ÷ pretax incomeInterest burden100%pretax ÷ operating incomeOperating margin48%operating income ÷ revenueAsset turnover0.66×revenue ÷ average assetsEquity multiplier1.93×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$163MFY2025
Income before tax$150MFY2025
Operating income$150MFY2025
$312MFY2025
Ending assets$826MFY2025
Beginning assets$119MFY2024
$405MFY2025
$84.7MFY2024
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full CORMEDIX INC. analysis at Buy Like Buffett